Cox Christopher Nixon 4
4 · Alto Neuroscience, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Cox Christopher Nixon
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-01$11.88/sh+4,623$54,940→ 4,623 totalExercise: $16.00Exp: 2034-01-31→ Common Stock (4,623 underlying) - Award
Stock Option (right to buy)
2024-02-01+30,574→ 30,574 totalExercise: $16.00Exp: 2034-01-31→ Common Stock (30,574 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date.
- [F2]840 shares underlying the option shall vest on March 31, 2024, and 1,261 shares underlying the option shall vest on each of June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service through each such vesting date.
- [F3]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $55,000.